Clinical Trial Update: A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients [NA]

View source ↗

Summary

A clinical trial is evaluating trastuzumab deruxtecan for HER2-positive breast cancer in Russian patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: HER2-positive Breast Cancer, Trastuzumab Deruxtecan | NA | Status: RECRUITING